Incyte (INCY) Reports Q2 Loss, Tops Revenue Estimates

This quarterly report represents an earnings surprise of -333.33%. A quarter ago, it was expected that this specialty drugmaker would post earnings of $0.88 per share when it actually produced earnings of $0.64, delivering a surprise of -27.27%. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. While Incyte has underperformed the market so far this year, the qu ...